Scott & Selber, Inc. Abb Vie Inc. Transaction History

Scott & Selber, Inc.

$322 Million
Q3 2024

A detailed history of Scott & Selber, Inc. transactions in Abb Vie Inc. stock. As of the latest transaction made, Scott & Selber, Inc. holds 18,289 shares of ABBV stock, worth $3.21 Million. This represents 1.12% of its overall portfolio holdings.

Number of Shares

18,289

Previous 24,352 24.9%

Holding current value

$3.21 Million

Previous $4.18 Million 13.53%

% of portfolio

1.12%

Previous 1.33%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 01, 2024	SELL	$163.84 - $199.33 $993,361 - $1.21 Million	-6,063 Reduced 24.9%	18,289 $3.61 Million
Q2 2024 Jul 29, 2024	BUY	$154.79 - $180.76 $25,385 - $29,644	164 Added 0.68%	24,352 $4.18 Million
Q1 2024 May 01, 2024	SELL	$159.82 - $182.1 $27,968 - $31,867	-175 Reduced 0.72%	24,188 $4.41 Million
Q4 2023 Feb 01, 2024	SELL	$137.6 - $154.97 $11,696 - $13,172	-85 Reduced 0.35%	24,363 $3.78 Million
Q3 2023 Oct 24, 2023	SELL	$133.59 - $154.65 $10,152 - $11,753	-76 Reduced 0.31%	24,448 $3.64 Million
Q2 2023 Jul 27, 2023	SELL	$132.51 - $164.9 $9,805 - $12,202	-74 Reduced 0.3%	24,524 $3.3 Million
Q1 2023 Apr 18, 2023	BUY	$144.61 - $166.54 $10,556 - $12,157	73 Added 0.3%	24,598 $3.92 Million
Q4 2022 Jan 31, 2023	BUY	$138.31 - $165.87 $6,362 - $7,630	46 Added 0.19%	24,525 $3.96 Million
Q3 2022 Oct 21, 2022	BUY	$134.21 - $153.93 $15,434 - $17,701	115 Added 0.47%	24,479 $3.29 Million
Q2 2022 Jul 28, 2022	BUY	$137.62 - $174.96 $7,293 - $9,272	53 Added 0.22%	24,364 $3.73 Million
Q1 2022 May 03, 2022	SELL	$131.98 - $163.75 $188,731 - $234,162	-1,430 Reduced 5.56%	24,311 $3.94 Million
Q4 2021 Feb 04, 2022	BUY	$107.43 - $135.93 $125,693 - $159,038	1,170 Added 4.76%	25,741 $3.49 Million
Q3 2021 Nov 05, 2021	BUY	$106.4 - $120.78 $546,364 - $620,205	5,135 Added 26.42%	24,571 $2.65 Million
Q2 2021 Aug 10, 2021	BUY	$105.21 - $117.21 $392,854 - $437,662	3,734 Added 23.78%	19,436 $2.19 Million
Q1 2021 May 04, 2021	BUY	$102.3 - $112.62 $8,900 - $9,797	87 Added 0.56%	15,702 $1.7 Million
Q4 2020 Feb 04, 2021	SELL	$80.49 - $108.67 $117,756 - $158,984	-1,463 Reduced 8.57%	15,615 $1.67 Million
Q3 2020 Oct 27, 2020	BUY	$85.91 - $100.83 $80,583 - $94,578	938 Added 5.81%	17,078 $1.5 Million
Q2 2020 Aug 04, 2020	BUY	$73.37 - $98.18 $1.18 Million - $1.58 Million	16,140 New	16,140 $1.59 Million

Others Institutions Holding ABBV

# of Institutions

3,853

Shares Held

1.25B

Call Options Held

16.8M

Put Options Held

12.2M

View Full List

About AbbVie Inc.

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $310B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

More about ABBV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Scott & Selber, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Scott & Selber, Inc. with notifications on news.

Account